SUWANEE, Ga., May 4, 2015 (GLOBE NEWSWIRE) -- Digirad Corporation (Nasdaq:DRAD), the leader in providing diagnostic services on an as needed, when needed and where needed basis, today announced that it will present at the B. Riley and Company Investor Conference on Tuesday, May 12, 2015, at the Loews Hollywood Hotel in Los Angeles.
In the presentation, taking place at 9:30 AM (PDT), Matt Molchan, President and CEO, and Jeff Keyes, CFO, will provide an overview of the Company's business. Mr. Molchan and Mr. Keyes will also be available for one-on-one meetings on-site at the conference that day.
An investor presentation and live webcast will be available from the Events & Presentations link on the Investor Relations page of the Digirad website at www.digirad.com.
Digirad delivers convenient, effective, and efficient diagnostic solutions on an as needed, when needed, and where needed basis. Digirad is one of the largest national providers of in-office nuclear cardiology and ultrasound imaging services, and also provides cardiac event monitoring services. These services are provided to physician practices, hospitals and imaging centers through its Diagnostic Services business. Digirad also sells medical diagnostic imaging systems, including solid-state gamma cameras, for nuclear cardiology and general nuclear medicine applications, as well as provides service on the products sold through its Diagnostic Imaging business. For more information, please visit www.digirad.com. Digirad® and Cardius® are registered trademarks of Digirad Corporation.
CONTACT: For more information contact: Jeffry Keyes Chief Financial Officer 858-726-1600 email@example.com